Core Viewpoint - The company announced that its subsidiary, Shanghai Heyu Biopharmaceutical Technology Co., Ltd., has received orphan drug designation (ODD) from the European Medicines Agency (EMA) for its self-developed selective oral small molecule FGFR4 inhibitor, Irpagratinib (ABSK-011), for the treatment of hepatocellular carcinoma (HCC) [1] Group 1 - The orphan drug designation will support the clinical development, registration, and commercialization process of Irpagratinib in Europe [1] - Irpagratinib is currently undergoing clinical studies in multiple locations worldwide [1]

Core Viewpoint - Fosun International (00656) has announced the granting of stock options and reward shares to its directors and employees as part of its equity incentive plans, which are aimed at aligning the interests of the management with those of the shareholders [1] Group 1: Stock Options - As of March 31, 2026, the company granted 363 million stock options to 160 eligible participants under the 2023 stock option plan, which requires acceptance from the option recipients to become effective [1] Group 2: Reward Shares - On the same date, the company also granted 29.77 million reward shares to 76 eligible participants under the 2023 reward plan [1] - The reward shares granted in 2026 will be fulfilled through the issuance of 26.60 million new shares within the authorized limit of the 2023 reward plan and by utilizing 3.18 million reward shares that have lapsed prior to vesting [1]

Group 1 - The investment management business continues to be a significant pillar for the group's performance growth and profit enhancement in 2025, with a stable asset management scale of 28.4 billion yuan by year-end [1] - The group has successfully executed orderly project exits, distributing approximately 2.5 billion yuan to LPs throughout the year, leading to an increase in fund DPI, with 5 out of 11 main funds exceeding 100% DPI [1] - The group achieved approximately 524 million yuan in income from attached rights in 2025, with a cumulative realization of about 1.3 billion yuan, indicating a strong cash flow and profit contribution from the investment management business [1] Group 2 - Huaxing Securities has made significant improvements in overall business performance during the reporting period, with revenue and net investment income reaching 294 million yuan, a year-on-year increase of 19% [2] - The operating loss narrowed by 52% to approximately 46 million yuan, with retail and brokerage business revenue growing by 55%, accounting for 43% of total revenue, becoming a key growth driver [2] - The asset management business has strengthened its research and investment capabilities, achieving rapid growth in both revenue and management scale, while the investment banking sector continues to focus on hard technology [2] Group 3 - Huaxing Capital Holdings reported an annual revenue of 1.066 billion yuan for the year ending December 31, 2025, representing a year-on-year increase of 37.19% [3] - The company turned a profit with a net profit attributable to shareholders of 101 million yuan, compared to a loss in the previous year, with earnings per share of 0.19 yuan [3]

Core Viewpoint - Shenzhou International (02313) reported a revenue of RMB 30.994 billion for the year ending December 31, 2025, reflecting an 8.13% year-on-year increase, while net profit attributable to shareholders decreased by 6.66% to RMB 5.825 billion [3][4] Group 1: Financial Performance - The company achieved a revenue of RMB 30.994 billion, which is an increase of 8.13% compared to the previous year [3] - Net profit attributable to shareholders was RMB 5.825 billion, down 6.66% year-on-year [3] - Earnings per share were reported at RMB 3.88, with a proposed final dividend of HKD 1.2 per share [3] Group 2: Product Sales Breakdown - Sales of sports products accounted for approximately 67.7% of total sales, increasing by about 5.9% compared to 2024, driven by higher demand in the US and European markets [3] - Sales of leisure products represented about 27.1% of total sales, showing a significant increase of approximately 16.7% from 2024, primarily due to increased demand in Japan and other markets [3] - Sales of underwear products made up around 4.5% of total sales, experiencing a slight decline of about 2.3% compared to 2024, attributed to decreased demand in the Japanese market [3] Group 3: Profitability Factors - The after-tax net profit for the year was approximately RMB 5.825 billion, a decrease of about 6.7% from 2024, mainly due to a one-time gain from the sale of a wholly-owned subsidiary in the previous year amounting to RMB 331 million [4] - The increase in the USD exchange rate in 2025 resulted in a foreign exchange loss of approximately RMB 256 million, contrasting with a foreign exchange gain of about RMB 105.5 million in 2024 [4]

Group 1 - The core viewpoint of the articles indicates that Shenzhou International's performance in the second half of 2025 was below expectations, with a revenue increase of only 2.2% year-on-year and a gross margin decline of 1.8 percentage points to 25.6%, marking a two-year low, which is significantly worse than market expectations for stable gross margins [1] - The decline in gross margin is attributed to factors such as tariffs, appreciation of the Renminbi, rising labor costs, and inefficiencies [1] - Looking ahead to 2026, the company is noted to have weak order momentum in January and February, with some improvement in March; the annual sales volume is expected to grow in the mid-single digits year-on-year, while average selling prices may slightly decline due to the Renminbi appreciation and ongoing adjustments by Nike and Puma [1] Group 2 - Daiwa has released a report stating that despite short-term adverse factors, Shenzhou International's current valuation is not expensive, and the firm maintains a "Buy" rating, lowering the target price from HKD 79 to HKD 73 [2]

分时图 日K线 周K线 月K线 46.78 -1.26 -2.62% 6.00% 4.00% 2.00% 0.00% 2.00% 4.00% 6.00% 45.16 46.12 47.08 48.04 49.00 49.96 50.92 09:30 10:30 12:00/13:00 14:00 16:10 0 39万 79万 118万 申洲国际(02313)午后跌超6%，截至发稿，跌6.03%，报49.1港元，成交额4.31亿港元。 申洲国际 消息面上，申洲国际午间发布2025年度业绩，该集团取得收入人民币309.94亿元(单位下同)，同比增加 8.13%；母公司拥有人应占权益58.25亿元，同比减少6.66%；每股盈利3.88元，拟派发末期股息每股1.2 港元，上年同期派1.28港元。连同已派发的中期息1.38港元，2025年全年建议派发股息合共2.58港元， 同比上升约2%。 ...

分时图 日K线 周K线 月K线 46.78 -1.26 -2.62% 6.00% 4.00% 2.00% 0.00% 2.00% 4.00% 6.00% 45.16 46.12 47.08 48.04 49.00 49.96 50.92 09:30 10:30 12:00/13:00 14:00 16:10 0 39万 79万 118万 申洲国际(02313)发布公告，于2026年3月31日该公司斥资1029.58万港元回购22.05万股，回购价格为每 股46.32-47.72港元。 申洲国际 ...

Group 1 - The company's revenue increased by 2% from $10.1 billion to $10.2 billion, driven by higher sales of pasta and palm oil, as well as rising palm oil prices [1] - Metro Pacific Tollways Corporation (MPTC) reported increased toll revenues and traffic in the Philippines, contributing to MPIC's revenue growth [1] - Regular profit rose by 10% from $672.5 million to $740 million, mainly due to higher contributions from MPIC and Indofood [1] Group 2 - The reported profit increased by 10% from $600.3 million to $661 million, reflecting the rise in regular profit [1] - The Indonesian rupiah depreciated less compared to the previous year, leading to a significant decrease in non-cash exchange losses related to bonds denominated in USD [1] - The company proposed a final dividend of 14.00 Hong Kong cents per share, with basic earnings per share of 15.53 cents [2]

Core Viewpoint - The company, China Merchants Port (00144), reported a revenue increase of 12.8% year-on-year, reaching HKD 13.354 billion, driven by business volume growth, but faced a decline in profit due to various financial factors [2]. Financial Performance - The profit attributable to equity holders decreased by 18.5% to HKD 6.457 billion, while the recurring profit fell by 13.8% to HKD 6.511 billion [2]. - Basic earnings per share were HKD 1.538, with a proposed final dividend of HKD 0.489 per share [2]. - Total assets as of December 31, 2025, amounted to HKD 177.534 billion, a 4.8% increase from the beginning of the year [2]. - Total liabilities rose by 5.1% to HKD 50.496 billion, compared to HKD 48.042 billion at the end of 2024 [2]. - Net assets attributable to equity holders increased by 6.3% to HKD 110.403 billion [2]. Operational Highlights - The company achieved a record container throughput of over 15 million TEUs at the Western Shenzhen Port, maintaining its leading position in the Guangdong-Hong Kong-Macao Greater Bay Area [3]. - The CICT in Sri Lanka strengthened its local market position with steady profit growth [3]. - The company signed a share purchase agreement for the Vast project in Brazil to expand its presence in Latin America [3]. - Container throughput at the TCP in Brazil exceeded 1.66 million TEUs, while the LCT in Togo became the first African terminal to regularly handle 24,000 TEU container ships, marking a 17.9% year-on-year increase [3]. - The Kumport in Turkey secured long-term service contracts, achieving a 22.8% year-on-year increase in container throughput [3].

Group 1 - The core viewpoint of the article highlights that China Merchants Port (00144) experienced a significant decline in its stock price, with a drop of over 4% in the afternoon session, currently trading at HKD 15.22, with a transaction volume of HKD 420.6 million [2] - The company reported a revenue of HKD 13.354 billion for the fiscal year 2025, reflecting a year-on-year increase of 12.8% [2] - However, the profit attributable to equity holders decreased by 18.5% to HKD 6.457 billion, and the recurring profit fell by 13.8% to HKD 6.511 billion, primarily due to a reduction in profits from joint ventures and increased credit loss provisions [2] - The proposed final dividend is HKD 0.489 per share, down from HKD 0.636 per share in the same period last year [2]